Amundi Increases Stake in Omega Healthcare Investors, Inc. $OHI

Amundi raised its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 125.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,298,280 shares of the real estate investment trust’s stock after acquiring an additional 721,611 shares during the quarter. Amundi’s holdings in Omega Healthcare Investors were worth $47,374,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Farther Finance Advisors LLC boosted its stake in shares of Omega Healthcare Investors by 7.1% during the 2nd quarter. Farther Finance Advisors LLC now owns 4,182 shares of the real estate investment trust’s stock worth $153,000 after acquiring an additional 279 shares in the last quarter. Guggenheim Capital LLC boosted its position in Omega Healthcare Investors by 1.0% during the second quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock worth $1,077,000 after purchasing an additional 280 shares in the last quarter. United Services Automobile Association boosted its position in Omega Healthcare Investors by 1.8% during the first quarter. United Services Automobile Association now owns 16,598 shares of the real estate investment trust’s stock worth $632,000 after purchasing an additional 291 shares in the last quarter. Coldstream Capital Management Inc. grew its holdings in Omega Healthcare Investors by 0.5% in the second quarter. Coldstream Capital Management Inc. now owns 60,924 shares of the real estate investment trust’s stock valued at $2,233,000 after purchasing an additional 301 shares during the period. Finally, CreativeOne Wealth LLC increased its position in shares of Omega Healthcare Investors by 3.4% in the first quarter. CreativeOne Wealth LLC now owns 9,487 shares of the real estate investment trust’s stock valued at $361,000 after buying an additional 310 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on OHI. Mizuho lifted their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, September 11th. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the company a “hold” rating in a report on Monday, December 1st. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $42.00 to $45.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 13th. Finally, Citigroup reaffirmed a “buy” rating and issued a $50.00 price target (up from $45.00) on shares of Omega Healthcare Investors in a research note on Wednesday, November 12th. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.63.

Omega Healthcare Investors Price Performance

OHI stock opened at $45.22 on Wednesday. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $46.36. The company has a debt-to-equity ratio of 0.95, a current ratio of 7.11 and a quick ratio of 7.11. The firm has a market capitalization of $13.36 billion, a PE ratio of 25.26, a price-to-earnings-growth ratio of 2.04 and a beta of 0.56. The business has a 50 day simple moving average of $42.78 and a 200-day simple moving average of $40.55.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. The firm had revenue of $311.59 million during the quarter, compared to analyst estimates of $262.48 million. During the same quarter in the prior year, the firm posted $0.71 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 14.4% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 3rd were issued a dividend of $0.67 per share. The ex-dividend date was Monday, November 3rd. This represents a $2.68 dividend on an annualized basis and a dividend yield of 5.9%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 149.72%.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, CEO C Taylor Pickett acquired 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were purchased at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the acquisition, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $862,800. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CIO Vikas Gupta acquired 11,500 shares of the business’s stock in a transaction that occurred on Thursday, November 6th. The shares were acquired at an average cost of $42.97 per share, with a total value of $494,155.00. Following the completion of the transaction, the executive directly owned 13,773 shares in the company, valued at approximately $591,825.81. The trade was a 505.94% increase in their position. The SEC filing for this purchase provides additional information. 1.50% of the stock is currently owned by insiders.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.